Stocks OST Financial statements
Financial statementsOstin Technology Group Co., Ltd. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Ostin Technology Group Co., Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 140 | 168 | 105 | 57.5 | 32.5 | 39.7 |
| Cost of revenue | 128 | 150 | 92.8 | 55.5 | 30.8 | 37.1 |
| Gross profit | 11.6 | 17.4 | 12.6 | 2.05 | 1.69 | 2.54 |
| Research and development | 2.83 | 5.71 | 2.52 | 2.78 | 1.7 | 2.53 |
| Selling and marketing | 2.17 | 3.97 | 2.79 | 2.39 | 2.05 | 2.22 |
| General and administrative | 3.12 | 4.99 | 7.65 | 7.34 | 7.57 | 6.99 |
| Operating expenses | 8.12 | 14.1 | 12.2 | 12.3 | 11.2 | 11.6 |
| Operating income | 3.46 | 3.22 | 0.45 | -10.3 | -9.53 | -9.08 |
| Interest expense | 0.13 | 0.07 | 0.01 | 0.06 | 0.14 | |
| Other non-operating income | -0.76 | 0.02 | -0.01 | -0.53 | -0.64 | -1.22 |
| Pre-tax income | 2.7 | 3.24 | 0.44 | -10.8 | -10.2 | -10.3 |
| Income tax | -0.13 | -0.06 | 0.33 | 0.23 | 0.02 | 0.02 |
| Net income to minority interests | -0.12 | 0.2 | -0.09 | -0.07 | -0.13 | -0.3 |
| Net income | 2.83 | 3.3 | 0.11 | -10.9 | -10.1 | -10 |
| EBITDA | 4.54 | 5.06 | 2.76 | -7.82 | -5.8 | -6.78 |
| EPS, basic | 57.70 | 64.11 | 4.27 | -196.59 | -168.50 | -4.38 |
| EPS, diluted | 57.69 | 64.11 | 4.27 | -196.59 | -168.50 | -4.38 |
| Shares, basic (weighted) | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 2.29 |
| Shares, diluted (weighted) | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 2.29 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 5.36 | 0.68 | 3.66 | 0.85 | 1.02 | 5.07 |
| Receivables | 0.1 | 6.27 | 6.48 | 3.92 | 3.52 | |
| Inventory | 18.7 | 15.4 | 14.4 | 11.1 | 6.35 | |
| Other current assets | 1.43 | 0.21 | 0.22 | 1.03 | 0.53 | |
| Total current assets | 54.2 | 31.9 | 24.4 | 20.8 | 18.4 | |
| Property, plant and equipment | 19.4 | 19.4 | 25.1 | 24.5 | 29.7 | |
| Lease right-of-use assets | 0.11 | 0.01 | 0.14 | 0.01 | ||
| Intangible assets | 0.13 | 2.97 | 4.98 | 4.26 | 3.58 | |
| Long-term investments | 0.21 | 0.21 | ||||
| Other non-current assets | 0.82 | 0.25 | ||||
| Total assets | 76 | 57.2 | 56.5 | 51.1 | 53.2 | |
| Accounts payable | 17.6 | 6.28 | 10.8 | 6.34 | 8.07 | |
| Short-term debt | 32.4 | 21 | 23.9 | 25 | 23.2 | |
| Total current liabilities | 60.6 | 31.6 | 40.5 | 41 | 39.7 | |
| Lease liabilities | 0.01 | 0.01 | ||||
| Other non-current liabilities | 0.19 | |||||
| Total liabilities | 60.8 | 31.6 | 42.5 | 43.2 | 42.3 | |
| Total debt | 0.19 | 1.64 | 1.71 | 2.39 | ||
| Paid-in capital | 10.9 | 23.3 | 23.3 | 24.5 | 36.1 | |
| Retained earnings | 2.75 | 2.48 | -8.47 | -18.5 | -28.5 | |
| Other comprehensive income | -0.32 | -1.9 | -2.33 | -2.24 | -2.23 | |
| Shareholders' equity | 14.3 | 25.3 | 14 | 5.19 | 7 | |
| Minority interests | 0.88 | 0.29 | 0.13 | 2.69 | 3.96 | |
| Total equity | 11.3 | 15.2 | 25.6 | 14.1 | 7.89 | 11 |
| Total liabilities and equity | 76 | 57.2 | 56.5 | 51.1 | 53.2 | |
| Shares outstanding | 0.05 | 0.56 | 14 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | 2.83 | 3.3 | 0.11 | -11 | -10.2 | -10.3 |
| Depreciation and amortization | 1.08 | 1.84 | 2.31 | 2.44 | 3.73 | 2.29 |
| Deferred income tax | -0.3 | 0.21 | 0.21 | 0.58 | -0.01 | -0.01 |
| Change in receivables | -6.71 | -15.2 | 18.4 | -0.4 | 1.81 | 0.2 |
| Change in inventory | -5.75 | -0.56 | 1.6 | 0.3 | 3.53 | 3.48 |
| Change in payables | 11.5 | -6.78 | -10.5 | 0.26 | -4.18 | 1.8 |
| Cash from operations | 7.72 | -17.7 | 9.7 | -2.59 | -4.94 | 0.09 |
| Capital expenditures | -3.7 | -6.21 | -5.12 | -4.48 | -2.42 | -7.2 |
| Cash from investing | -5.18 | -5.2 | -6.88 | -6.99 | -1.39 | -7.29 |
| Debt repaid | -0.89 | |||||
| Stock issued | 0.1 | 12.4 | 2.48 | 1.66 | ||
| Cash from financing | 0.21 | 18.6 | 0.01 | 7.72 | 6.75 | 10.9 |
| Exchange rate effect | 0.13 | -0.38 | 0.29 | -0.79 | -0.23 | 0.3 |
| Net change in cash | 2.89 | -4.68 | 3.12 | -2.65 | 0.18 | 4.05 |
| Free cash flow | 4.02 | -23.9 | 4.58 | -7.08 | -7.36 | -7.12 |
| Interest paid | 0.53 | 0.75 | 1.01 | 1.01 | 1.2 | 1.56 |
| Income taxes paid | 0.27 | 0.37 | 0.24 | -0.08 | 0 | 0 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 6.4% | Gross profit / revenue. |
| Operating margin | -22.9% | Operating income / revenue. |
| EBITDA margin | -17.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -25.9% | Pre-tax income / revenue. |
| Net margin | -25.2% | Net income / revenue. |
| FCF margin | -17.9% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 0.2% | Cash from operations / revenue. |
| Return on equity (ROE) | -164.3% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -19.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | -140.7% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 6.4% | Research and development expense / revenue. |
| Capex / revenue | 18.2% | Capital expenditures / revenue. |
| D&A / revenue | 5.8% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 22.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -27.8% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -22.3% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 50.6% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -41.4% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -26.2% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 3y | -79.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -59.4% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 34.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -34.9% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 4.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -2.4% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 3,725.0% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 265.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 117.1% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.46x | Current assets / current liabilities. |
| Quick ratio | 0.22x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.13x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.34x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 4.5% | Total debt / total assets. |
| Liabilities / assets | 79.4% | Total liabilities / total assets. |
| Net debt | -$2.7M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | -64.0x | Operating income / interest expense. |
| Working capital | -$21.4M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 6.7% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $3.4M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.76x | Revenue / average total assets. |
| Fixed asset turnover | 1.46x | Revenue / average property, plant and equipment. |
| Inventory turnover | 4.25x | Cost of revenue / average inventory. |
| Days inventory | 86 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 10.7x | Revenue / average receivables. |
| Days sales outstanding | 34 days | 365 x average receivables / revenue. |
| Days payables | 71 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 49 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 8,449.0% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$4.38 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | -$4.38 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $17.36 | Revenue / diluted weighted shares. |
| FCF per share | -$3.11 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.04 | Cash from operations / diluted weighted shares. |
| Book value per share | $3.06 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.50 | Tangible book value / shares outstanding. |
| Cash per share | $2.22 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $23.7M | Share price x shares outstanding. |
| Enterprise value | $21.1M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.60x | Market cap / revenue. |
| P/B | 3.39x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 6.94x | Market cap / tangible book value, when positive. |
| P/OCF | 278x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.53x | Enterprise value / revenue. |
| FCF yield | -30.0% | Free cash flow / market cap. |
| Earnings yield | -42.2% | Net income / market cap (the inverse of P/E). |
What was Ostin Technology Group Co., Ltd.'s revenue in fiscal 2025?
Ostin Technology Group Co., Ltd. reported revenue of $39.7M for fiscal 2025, 22.2% higher than the year before.
Was Ostin Technology Group Co., Ltd. profitable in fiscal 2025?
No. It reported a net loss of $10.0M.
How much free cash flow did Ostin Technology Group Co., Ltd. generate in fiscal 2025?
Cash from operations of $85.2K minus capital expenditures of $7.2M left free cash flow of -$7.1M.